An adaptable method using human mixed tissue ratiometric controls for benchmarking performance on gene expression microarrays in clinical laboratories

Pine, P. Scott; Rosenzweig, Barry A.; Thompson, Karol L.
January 2011
BMC Biotechnology;2011, Vol. 11 Issue 1, p38
Academic Journal
Background: Molecular biomarkers that are based on mRNA transcripts are being developed for the diagnosis and treatment of a number of diseases. DNA microarrays are one of the primary technologies being used to develop classifiers from gene expression data for clinically relevant outcomes. Microarray assays are highly multiplexed measures of comparative gene expression but have a limited dynamic range of measurement and show compression in fold change detection. To increase the clinical utility of microarrays, assay controls are needed that benchmark performance using metrics that are relevant to the analysis of genomic data generated with biological samples. Results: Ratiometric controls were prepared from commercial sources of high quality RNA from human tissues with distinctly different expression profiles and mixed in defined ratios. The samples were processed using six different target labeling protocols and replicate datasets were generated on high density gene expression microarrays. The area under the curve from receiver operating characteristic plots was calculated to measure diagnostic performance. The reliable region of the dynamic range was derived from log2 ratio deviation plots made for each dataset. Small but statistically significant differences in diagnostic performance were observed between standardized assays available from the array manufacturer and alternative methods for target generation. Assay performance using the reliable range of comparative measurement as a metric was improved by adjusting sample hybridization conditions for one commercial kit. Conclusions: Process improvement in microarray assay performance was demonstrated using samples prepared from commercially available materials and two metrics - diagnostic performance and the reliable range of measurement. These methods have advantages over approaches that use a limited set of external controls or correlations to reference sets, because they provide benchmark values that can be used by clinical laboratories to help optimize protocol conditions and laboratory proficiency with microarray assays.


Related Articles

  • Alternative Splicing in Prostate and Breast Cancer. Watson, Patricia M.; Watson, Dennis K. // Open Cancer Journal;2010 Special Issue, p62 

    Alternative splicing of mRNA precursors allows the synthesis of multiple mRNAs from a single primary transcript, thus contributing to proteomic diversity in higher eukaryotes. Multiple studies demonstrate that alternative splicing patterns are altered during cancer progression. Several different...

  • TIPMaP: a web server to establish transcript isoform profiles from reliable microarray probes. Chitturi, Neelima; Balagannavar, Govindkumar; Chandrashekar, Darshan S.; Abinaya, Sadashivam; Srini, Vasan S.; Acharya, Kshitish K. // BMC Genomics;2013, Vol. 14 Issue 1, p1 

    Background Standard 3' Affymetrix gene expression arrays have contributed a significantly higher volume of existing gene expression data than other microarray platforms. These arrays were designed to identify differentially expressed genes, but not their alternatively spliced transcript forms....

  • "Per cell" normalization method for mRNA measurement by quantitative PCR and microarrays. Kanno, Jun; Aisaki, Ken-ichi; Igarashi, Katsuhide; Nakatsu, Noriyuki; Ono, Atsushi; Kodama, Yukio; Nagao, Taku // BMC Genomics;2006, Vol. 7, p64 

    Background: Transcriptome data from quantitative PCR (Q-PCR) and DNA microarrays are typically obtained from a fixed amount of RNA collected per sample. Therefore, variations in tissue cellularity and RNA yield across samples in an experimental series compromise accurate determination of the...

  • Bronchial epithelial cells as a new source for differential transcriptome analysis after lung transplantation Skawran, Britta; Dierich, Martin; Steinemann, Doris; Hohlfeld, Jens; Haverich, Axel; Schlegelberger, Brigitte; Welte, Tobias; von Neuhoff, Nils // European Journal of Cardio-Thoracic Surgery;Oct2009, Vol. 36 Issue 4, p715 

    Abstract: Objective: The early diagnosis of chronic organ rejection after lung transplantation (LTx) is currently hampered by the lack of reliable diagnostic markers. The present study aims to establish the procedure of gene expression profiling in bronchial epithelial cells for the...

  • Post-analysis follow-up and validation of microarray experiments. Chuaqui, Rodrigo F.; Bonner, Robert F.; Best, Carolyn J.M.; Gillespie, John W.; Flaig, Michael J.; Hewitt, Stephen M.; Phillips, John L.; Krizman, David B.; Tangrea, Michael A.; Ahram, Mamoun; Linehan, W. Marston; Knezevic, Vladimir; Emmert-Buck, Michael R. // Nature Genetics;Dec2002 Supplement 2, Vol. 32, p509 

    Measurement of gene-expression profiles using microarray technology is becoming increasingly popular among the biomedical research community. Although there has been great progress in this field, investigators are still confronted with a difficult question after completing their experiments: how...

  • Navigating gene expression using microarrays ? a technology review. Schulze, Almut; Downward, Julian // Nature Cell Biology;Aug2001, Vol. 3 Issue 8, pE190 

    Parallel quantification of large numbers of messenger RNA transcripts using microarray technology promises to provide detailed insight into cellular processes involved in the regulation of gene expression. This should allow new understanding of signalling networks that operate in the cell and of...

  • An Integrated Analysis of miRNA and mRNA Expressions in Non-Small Cell Lung Cancers. Lina Ma; Yanyan Huang; Wangyu Zhu; Shiquan Zhou; Jihang Zhou; Fang Zeng; Xiaoguang Liu; Yongkui Zhang; Jun Yu // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Using DNA microarrays, we generated both mRNA and miRNA expression data from 6 non-small cell lung cancer (NSCLC) tissues and their matching normal control from adjacent tissues to identify potential miRNA markers for diagnostics. We demonstrated that hsa-miR-96 is significantly and consistently...

  • The tissue microarray data exchange specification: implementation by the Cooperative Prostate Cancer Tissue Resource. Berman, Jules J.; Datta, Milton; Kajdacsy-Balla, Andre; Melamed, Jonathan; Orenstein, Jan; Dobbin, Kevin; Patel, Ashok; Dhir, Rajiv; Becich, Michael J. // BMC Bioinformatics;2004, Vol. 5, p19 

    Background: Tissue Microarrays (TMAs) have emerged as a powerful tool for examining the distribution of marker molecules in hundreds of different tissues displayed on a single slide. TMAs have been used successfully to validate candidate molecules discovered in gene array experiments. Like gene...

  • The Role of microRNAs in the Biology of Rare Diseases. Salvatore, Marco; Magrelli, Armando; Taruscio, Domenica // International Journal of Molecular Sciences;Oct2011, Vol. 12 Issue 10, p6733 

    Rare diseases (RD) are characterized by low prevalence and affect not more than five individuals per 10,000 in the European population; they are a large and heterogeneous group of disorders including more than 7,000 conditions and often involve all organs and tissues, with several clinical...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics